Asia-Pacific IVF Services Market by Cycle Type (Fresh IVF Cycle, Thawed IVF Cycle and Donor egg IVF cycle) and End-User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes): Analysis and Industry Forecast, 20192028
- Published Date: 2020-11-18
- Report ID: 18177
- Pages: 372
-
Format:
The Asia-Pacific IVF Services Market was valued at $8,100.04 million in 2018 and is expected to reach $24,216.42 million by 2028, registering a CAGR of 11.6% from 2019 to 2028. IVF is a complex series of procedure used to help by fertility or avoid genetic problems and assist with the conception of a child. Throughout IVF, mature eggs are collected from ovaries and fertilized by sperm in a lab The Asia-Pacific IVF services market is anticipated to exhibit significant market growth during the forecast period, owing to rise in infertility rate, increase in trend of delayed pregnancies, surge in IVF success rate, and rise in disposable income in the region. However, complications associated with IVF treatment and lower awareness regarding IVF in some under developed regions hinders the growth of the market. Furthermore, surge in fertility tourism, increase in number of fertility clinics, and growth opportunities in emerging markets make way for the development of the Asia-Pacific IVF market in the future.
Asia-Pacific presents productive opportunities for the players operating in the IVF services market, owing to its high population base, growth in knowledge about IVF treatment, low costs of the IVF treatments, Delayed pregnancy trends rise in number of infertile populations, and surge in disposable income. In older women (more than 40 years age group), the eggs produced by the reproductive system are not fully formed for the process of fertilization. This may result in the risk of genetic disorders in the egg. Moreover, aging individuals experience a decline in the production of healthy eggs and increased chance of miscarriage. Thus, increase in trend of delayed pregnancy in women is anticipated to drive the growth of the IVF services market.
The Asia-Pacific IVF services market is segmented on the basis of cycle type, end user, and country. By cycle type, it is divided into fresh IVF cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycle. On the basis of end user, it is classified as fertility clinics, hospitals, surgical centers, and clinical research institutes. Country wise, the market is studied across India, China, Japan, Australia, New Zealand, South Korea, Thailand, Singapore, Malaysia, Indonesia, the Philippines, Vietnam, Myanmar, and Rest of Asia-Pacific.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets
It offers a quantitative analysis from 2018 to 2028, which is expected to enable the stakeholders to capitalize on prevailing market opportunities
Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
Key players are profiled to understand the competitive outlook of the Asia-Pacific market.
KEY MARKET SEGMENTS
By Cycle Type
Fresh IVF Cycles (Non-Donor)
Thawed IVF Cycles (Non-Donor)
Donor Egg IVF Cycles
By End User
Fertility Clinics
Hospitals
Surgical centers
Clinical research institutes
By Country
Asia Pacific
o Japan
o India
o China
o Australia
o New Zealand
o South Korea
o Thailand
o Singapore
o Malaysia
o Indonesia
o Philippines
o Vietnam
o Myanmar
o Rest of Asia-Pacific
LIST OF KEY PLAYERS PROFILED IN THE REPORT
The list of key players profiled in this report include Apollo Hospitals Dhaka, Australian Concept Infertility Medical Center (ACIMC), Bahosi Fertility Centre, Bangkok IVF center, Bloom Fertility and Healthcare, Bloom Fertility Center, Bourn Hall Fertility Center, Bumrungrad International Hospital, Center for Advanced Reproductive Medicine and Infertility, CHA Fertility Center, Chennai Fertility Center, Cloudnine Fertility, Damai Service Hospital, Fatemieh Infertility Center, Fertility Associates, Fertility Centre Nepal (Part of Wecare Health Services, India), Fertility First, Flinders Reproductive Medicine Pty Ltd, Genea Oxford Fertility Limited, IHH Healthcare Berhad, IVF NAMBA Clinic, IVF Sri Lanka Life Plus (Pvt) Ltd, IVF Van Hanh, KL Fertility & Gynecology Centre, Lanka Hospitals, LIFE - Lahore Institute of Fertility & Endocrinology, Lotus Fertility Clinic, Manipal Fertility, Maria Fertility Hospital, MEHR IVF Clinic, Monash IVF Wesley Hospital Auchenflower, Morpheus Life Sciences Pvt. Ltd., Morula IVF, National University Hospital, Nepal International Fertility Centre, Oak Medical Group/Oak Clinic, Raffles Medical Group, Repromed, RSUP Dr. Hasan Sadikin Bandung, SAFE Fertility Center, Sanno Hospital, Saqib Fertility & IVF Center Mid City Hospital, Shanghai Ji Ai Genetics & IVF Institute, Shanghai, United Family Hospital, Southend Fertility and IVF, Superior A.R.T Myanmar, Thomson Medical Pte. Ltd., TMC Fertility Centre, Tu Du Hospital, Victory A.R.T. Laboratory Phils., Inc., and Virtus Health.
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key Findings of the Study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Asia-Pacific IVF Services Market, By End User
3.2.1. Market size and forecast
3.2.2. Market volume and forecast
3.2.3. Fertility clinics
3.2.3.1. Market size and forecast
3.2.4. Hospitals
3.2.4.1. Market size and forecast
3.2.5. Surgical centers
3.2.5.1. Market size and forecast
3.2.6. Clinical research institutes
3.2.6.1. Market size and forecast
3.3. Asia-Pacific IVF Services Market, by Cycle Type
3.3.1. Market size and forecast
3.3.2. Market volume and forecast
3.3.3. Fresh IVF cycles (non-donor)
3.3.3.1. Market size and forecast
3.3.4. Thawed IVF cycles (non-donor)
3.3.4.1. Market size and forecast
3.3.5. Donor egg IVF cycles
3.3.5.1. Market size and forecast
3.4. Asia-Pacific IVF services market, by country
3.4.1. Limitations of foreign investment
3.4.1.1. India
3.4.1.2. China
3.4.1.3. Japan
3.4.1.4. Australia
3.4.1.5. New Zealand
3.4.1.6. South Korea
3.4.1.7. Thailand
3.4.1.8. Singapore
3.4.1.9. Malaysia
3.4.1.10. Indonesia
3.4.1.11. Philippines
3.4.1.12. Vietnam
3.4.1.13. Myanmar
3.4.2. Market size and forecast
3.4.3. Market volume and forecast
3.5. Market Dynamics
3.5.1. Drivers
3.5.1.1. Delayed pregnancies in women
3.5.1.2. Increase in global infertility rates
3.5.1.3. Increase in gamete donations
3.5.1.4. Increase in disposable income
3.5.1.5. Increase in IVF success rates
3.5.2. Restraints
3.5.2.1. Complications associated with IVF treatment
3.5.2.2. Low awareness level
3.5.3. Opportunities
3.5.3.1. Fertility tourism
3.5.3.2. Growth opportunities in the Asia-Pacific region
3.5.3.3. Increase in number of fertility clinics
3.5.4. Impact analyses
CHAPTER 4: INDIA IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)
4.1. Overview
4.1.1. Market size and forecast
4.2. Fertility Center in India
4.3. India IVF Services Market, By End User
4.3.1. Market size and forecast
4.3.2. Market volume and forecast
4.3.3. Fertility clinics
4.3.4. Hospitals
4.3.5. Surgical Centers
4.3.6. Clinical research institutes
4.4. India IVF Services Market, By Cycle Type
4.4.1. Market size and forecast
4.4.2. Market volume and forecast
4.4.3. Fresh IVF cycles (non-donor)
4.4.4. Thawed IVF cycles (non-donor)
4.4.5. Donor egg IVF cycles
4.5. Market Dynamics
4.5.1. Driving factors
4.5.2. Restraining factors
4.6. Regulatory Issues, Legislations and Authorities
4.7. Insurance Reimbursement Scenario
4.8. Company Profiles
4.8.1. Bourn Hall Fertility Center
4.8.1.1. Company overview
4.8.2. Southend Fertility and IVF
4.8.2.1. Company overview
4.8.3. Morpheus Life Sciences Pvt. Ltd.
4.8.3.1. Company overview
4.8.4. Bloom Fertility Center
4.8.4.1. Company overview
4.8.5. Bloom Fertility and Healthcare
4.8.5.1. Company overview
4.8.6. Manipal Fertility
4.8.6.1. Company overview
4.8.7. Cloudnine Fertility
4.8.7.1. Company overview
4.8.8. Chennai Fertility Center
4.8.8.1. Company overview
CHAPTER 5: CHINA IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)
5.1. Overview
5.1.1. Market size and forecast
5.2. China IVF Services Market, By End User
5.2.1. Market size and forecast
5.2.2. Market volume and forecast
5.2.3. Fertility clinics
5.2.4. Hospitals
5.2.5. Surgical Centers
5.2.6. Clinical research institutes
5.3. China IVF Services Market, By Cycle Type
5.3.1. Market size and forecast
5.3.2. Market volume and forecast
5.3.3. Fresh IVF cycles (non-donor)
5.3.4. Thawed IVF cycles (non-donor)
5.3.5. Donor egg IVF cycles
5.4. Market Dynamics
5.4.1. Driving factors
5.4.2. Restraining Factors
5.5. Regulatory Issues, Legislations and Authorities
5.6. Insurance Reimbursement Scenario
5.7. Company Profiles
5.7.1. Shanghai Ji Ai Genetics & IVF Institute
5.7.1.1. Company overview
5.7.2. Shanghai United Family Hospital
5.7.2.1. Company overview
CHAPTER 6: JAPAN IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)
6.1. Overview
6.1.1. Market size and forecast
6.2. Japan IVF services market, by end user
6.2.1. Market size and forecast
6.2.2. Market volume and forecast
6.2.3. Fertility clinics
6.2.4. Hospitals
6.2.5. Surgical Centers
6.2.6. Clinical research institutes
6.3. Japan IVF Services Market, By Cycle Type
6.3.1. Market size and forecast
6.3.2. Market volume and forecast
6.3.3. Fresh IVF cycles (non-donor)
6.3.4. Thawed IVF cycles (non-donor)
6.3.5. Donor egg IVF cycles
6.4. Market Dynamics
6.4.1. Driving factors
6.4.2. Restraining Factors
6.5. Regulatory Issues, Legislations and Authorities
6.6. Insurance Reimbursement Scenario
6.7. Company Profiles
6.7.1. IVF NAMBA Clinic
6.7.1.1. Company overview
6.7.2. Sanno Hospital
6.7.2.1. Company overview
6.7.3. Oak Medical Group/Oak Clinic
6.7.3.1. Company overview
CHAPTER 7: AUSTRALIA IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)
7.1. Overview
7.1.1. Market size and forecast
7.2. Fertility Center in Australia
7.3. Australia IVF Services Market, By End User
7.3.1. Market size and forecast
7.3.2. Market volume and forecast
7.3.3. Fertility clinics
7.3.4. Hospitals
7.3.5. Surgical Centers
7.3.6. Clinical research institutes
7.4. Australia IVF Services Market, By Cycle Type
7.4.1. Market size and forecast
7.4.2. Market volume and forecast
7.4.3. Fresh IVF cycles (non-donor)
7.4.4. Thawed IVF cycles (non-donor)
7.4.5. Donor egg IVF cycles
7.5. Market Dynamics
7.5.1. Driving factors
7.5.2. Restraining Factors
7.6. Regulatory Issues, Legislations and Authorities
7.7. Insurance Reimbursement Scenario
7.8. Company Profiles
7.8.1. Virtus Health
7.8.1.1. Company overview
7.8.2. Monash IVF Wesley Hospital Auchenflower
7.8.2.1. Company overview
7.8.3. Fertility First
7.8.3.1. Company overview
7.8.4. Flinders Reproductive Medicine Pty Ltd
7.8.4.1. Company overview
CHAPTER 8: NEW ZEALAND IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)
8.1. Overview
8.1.1. Market size and forecast
8.2. New Zealand IVF Services Market, By End User
8.2.1. Market size and forecast
8.2.2. Market volume and forecast
8.2.3. Fertility clinics
8.2.4. Hospitals
8.2.5. Surgical Centers
8.2.6. Clinical research institutes
8.3. New Zealand IVF Services Market, By Cycle Type
8.3.1. Market size and forecast
8.3.2. Market volume and forecast
8.3.3. Fresh IVF cycles (non-donor)
8.3.4. Thawed IVF cycles (non-donor)
8.3.5. Donor egg IVF cycles
8.4. Market Dynamics
8.4.1. Driving factors
8.4.2. Restraining Factors
8.5. Regulatory Issues, Legislations and Authorities
8.6. Insurance Reimbursement Scenario
8.7. Company Profiles
8.7.1. Fertility Associates
8.7.1.1. Company overview
8.7.2. Genea Oxford Fertility Limited
8.7.2.1. Company overview
8.7.3. Repromed
8.7.3.1. Company overview
CHAPTER 9: SOUTH KOREA IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)
9.1. Overview
9.1.1. Market size and forecast
9.2. Fertility Center in South Korea
9.3. South Korea IVF Services Market, By End User
9.3.1. Market size and forecast
9.3.2. Market volume and forecast
9.3.3. Fertility clinics
9.3.4. Hospitals
9.3.5. Surgical Centers
9.3.6. Clinical research institutes
9.4. South Korea IVF Services Market, By Cycle Type
9.4.1. Market size and forecast
9.4.2. Market volume and forecast
9.4.3. Fresh IVF cycles (non-donor)
9.4.4. Thawed IVF cycles (non-donor)
9.4.5. Donor egg IVF cycles
9.5. Market Dynamics
9.5.1. Driving factors
9.5.2. Restraining Factors
9.6. Regulatory Issues, Legislations and Authorities
9.7. Insurance Reimbursement Scenario
9.8. Company Profiles
9.8.1. CHA Fertility Center
9.8.1.1. Company overview
9.8.2. Maria Fertility Hospital
9.8.2.1. Company overview
CHAPTER 10: THAILAND IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)
10.1. Overview
10.1.1. Market size and forecast
10.2. Thailand IVF Services Market, By End User
10.2.1. Market size and forecast
10.2.2. Market volume and forecast
10.2.3. Fertility clinics
10.2.4. Hospitals
10.2.5. Surgical Centers
10.2.6. Clinical research institutes
10.3. Thailand IVF Services Market, By Cycle Type
10.3.1. Market size and forecast
10.3.2. Market volume and forecast
10.3.3. Fresh IVF cycles (non-donor)
10.3.4. Thawed IVF cycles (non-donor)
10.3.5. Donor egg IVF cycles
10.4. Market Dynamics
10.4.1. Driving factors
10.4.2. Restraining Factors
10.5. Regulatory Issues, Legislations and Authorities
10.6. Insurance Reimbursement Scenario
10.7. Company Profiles
10.7.1. SAFE Fertility Center
10.7.1.1. Company overview
10.7.2. Bangkok IVF Center (Bangkok Hospital)
10.7.2.1. Company overview
10.7.3. Bangkok IVF center
10.7.3.1. Company overview
CHAPTER 11: SINGAPORE IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)
11.1. Overview
11.1.1. Market size and forecast
11.2. Singapore IVF Services Market, By End User
11.2.1. Market size and forecast
11.2.2. Market volume and forecast
11.2.3. Fertility clinics
11.2.4. Hospitals
11.2.5. Surgical Centers
11.2.6. Clinical research institutes
11.3. Singapore IVF Services Market, By Cycle Type
11.3.1. Market size and forecast
11.3.2. Market volume and forecast
11.3.3. Fresh IVF cycles (non-donor)
11.3.4. Thawed IVF cycles (non-donor)
11.3.5. Donor egg IVF cycles
11.4. Market Dynamics
11.4.1. Driving factors
11.4.2. Restraining factors
11.5. Regulatory Issues, Legislations and Authorities
11.6. Insurance Reimbursement Scenario
11.7. Company Profiles
11.7.1. National University Hospital
11.7.1.1. Company overview
11.7.2. IHH Healthcare Berhad
11.7.2.1. Company overview
11.7.3. Thomson Medical Pte. Ltd.
11.7.3.1. Company overview
11.7.4. Raffles Medical Group
11.7.4.1. Company overview
CHAPTER 12: MALAYSIA IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)
12.1. Overview
12.1.1. Market size and forecast
12.2. Malaysia IVF Services Market, By End User
12.2.1. Market size and forecast
12.2.2. Market volume and forecast
12.2.3. Fertility clinics
12.2.4. Hospitals
12.2.5. Surgical Centers
12.2.6. Clinical research institutes
12.3. Malaysia IVF Services Market, By Cycle Type
12.3.1. Market size and forecast
12.3.2. Market volume and forecast
12.3.3. Fresh IVF cycles (non-donor)
12.3.4. Thawed IVF cycles (non-donor)
12.3.5. Donor egg IVF cycles
12.4. Market Dynamics
12.4.1. Driving factors
12.4.2. Restraining factors
12.5. Regulatory Issues, Legislations and Authorities
12.6. Insurance Reimbursement Scenario
12.7. Company Profiles
12.7.1. Damai Service Hospital
12.7.1.1. Company overview
12.7.2. TMC Fertility Centre
12.7.2.1. Company overview
12.7.3. KL Fertility & Gynecology Centre
12.7.3.1. Company overview
CHAPTER 13: INDONESIA IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)
13.1. Overview
13.1.1. Market size and forecast
13.2. Indonesia IVF Services Market, By End User
13.2.1. Market size and forecast
13.2.2. Market volume and forecast
13.2.3. Fertility clinics
13.2.4. Hospitals
13.2.5. Surgical Centers
13.2.6. Clinical research institutes
13.3. Indonesia IVF Services Market, By Cycle Type
13.3.1. Market size and forecast
13.3.2. Market volume and forecast
13.3.3. Fresh IVF cycles (non-donor)
13.3.4. Thawed IVF cycles (non-donor)
13.3.5. Donor egg IVF cycles
13.4. Market Dynamics
13.4.1. Driving factors
13.4.2. Restraining factors
13.5. Regulatory Issues, Legislations and Authorities
13.6. Insurance Reimbursement Scenario
13.7. Company Profiles
13.7.1. Morula IVF
13.7.1.1. Company overview
13.7.2. Lotus Fertility Clinic
13.7.2.1. Company overview
13.7.3. RSUP Dr. Hasan Sadikin Bandung
13.7.3.1. Company overview
CHAPTER 14: PHILIPPINES IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)
14.1. Overview
14.1.1. Market size and forecast
14.2. Philippines IVF Services Market, By End User
14.2.1. Market size and forecast
14.2.2. Market volume and forecast
14.2.3. Fertility clinics
14.2.4. Hospitals
14.2.5. Surgical Centers
14.2.6. Clinical research institutes
14.3. Philippines IVF Services Market, By Cycle Type
14.3.1. Market size and forecast
14.3.2. Market volume and forecast
14.3.3. Fresh IVF cycles (non-donor)
14.3.4. Thawed IVF cycles (non-donor)
14.3.5. Donor egg IVF cycles
14.4. Market Dynamics
14.4.1. Driving factors
14.4.2. Restraining factors
14.5. Regulatory Issues, Legislations and Authorities
14.6. Insurance Reimbursement Scenario
14.7. Company Profiles
14.7.1. Victory A.R.T. Laboratory Phils., Inc.
14.7.1.1. Company overview
14.7.2. Center for Advanced Reproductive Medicine and Infertility
14.7.2.1. Company overview
CHAPTER 15: VIETNAM IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)
15.1. Overview
15.1.1. Market size and forecast
15.2. Vietnam IVF Services Market, By End User
15.2.1. Market size and forecast
15.2.2. Market volume and forecast
15.2.3. Fertility clinics
15.2.4. Hospitals
15.2.5. Surgical Centers
15.2.6. Clinical research institutes
15.3. Vietnam IVF Services Market, By Cycle Type
15.3.1. Market size and forecast
15.3.2. Market volume and forecast
15.3.3. Fresh IVF cycles (non-donor)
15.3.4. Thawed IVF cycles (non-donor)
15.3.5. Donor egg IVF cycles
15.4. Market Dynamics
15.4.1. Driving factors
15.4.2. Restraining factors
15.5. Regulatory Issues, Legislations and Authorities
15.6. Insurance Reimbursement Scenario
15.7. Company Profiles
15.7.1. IVF Van Hanh
15.7.1.1. Company overview
15.7.2. Tu Du Hospital
15.7.2.1. Company overview
CHAPTER 16: MYANMAR IVF SERVICES MARKET (REVENUE AND NUMBER OF CYCLES)
16.1. Overview
16.2. Market size and forecast
16.3. Myanmar IVF Services Market, By End User
16.3.1. Market size and forecast
16.3.2. Market volume and forecast
16.3.3. Fertility clinics
16.3.4. Hospitals
16.3.5. Surgical centers
16.3.6. Clinical research institutes
16.4. Myanmar IVF Services Market, By Cycle Type
16.4.1. Market size and forecast
16.4.2. Market volume and forecast
16.4.3. Fresh IVF cycles (non-donor)
16.4.4. Thawed IVF cycles (non-donor)
16.5. Market Dynamics
16.5.1. Driving factors
16.5.2. Restraining factors
16.6. Regulatory issues, legislations, and authorities
16.7. Insurance Reimbursement Scenario
16.8. Company Profiles
16.8.1. Bahosi Fertility Centre
16.8.1.1. Company overview
16.8.2. Bumrungrad International Hospital
16.8.2.1. Company overview
16.8.3. Superior A.R.T Myanmar
16.8.3.1. Company overview
CHAPTER 17: REST OF ASIA-PACIFIC IVF SERVICES MARKET (REVENUE AND NUMBER OF CYCLES)
17.1. Overview
17.1.1. Market size and forecast
17.2. Rest of Asia-Pacific IVF Services Market, By End User
17.2.1. Market size and forecast
17.2.2. Market volume and forecast
17.2.3. Fertility clinics
17.2.4. Hospitals
17.2.5. Surgical centers
17.2.6. Clinical research institutes
17.3. Rest of Asia-Pacific IVF Services Market, By Cycle Type
17.3.1. Market size and forecast
17.3.2. Market volume and forecast
17.3.3. Fresh IVF cycles (non-donor)
17.3.4. Thawed IVF cycles (non-donor)
17.3.5. Donor egg IVF cycles
17.4. Market Dynamics
17.4.1. Driving factors
17.4.2. Restraining factors
17.5. Regulatory issues, legislations, and authorities
17.6. Insurance Reimbursement Scenario
17.7. Company Profiles
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
